Home > Insider Trading > Filing (0001127602-24-010623)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1682852	Moderna Inc.	MRNA	Biological Products, (No Disgnostic Substances) (2836)	813467528

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1760669	Stephen Hoge	C/O Moderna, Inc. 200 Technology Square Cambridge MA 02139	President	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2024-03-15	15,000	$103.17	1,501,241	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	4,116	Indirect	By Valhalla, LLC
Common Stock	151,933	Indirect	By Trust

Footnotes

The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 15, 2023.
These shares are owned directly by a trust for the benefit of Dr. Hoge's spouse and children, of which his spouse is a trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose.